ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...2425262728293031323334...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  New Research Aims to Optimize Therapy Against Onchocerciasis. (Pubmed Central) -  Aug 30, 2022   
    Therefore, new treatments for onchocerciasis are critical to accelerating the rate of elimination of this blinding disease. Here we discuss an ongoing study of a new treatment for onchocerciasis.
  • ||||||||||  ivermectin oral / Generic mfg., fluoxetine / Generic mfg.
    Preclinical, Journal:  PharmacoGenetic targeting of a C. elegans essential neuron provides an in vivo screening for novel modulators of nematode ion channel function. (Pubmed Central) -  Aug 24, 2022   
    Indeed, the developmental progression is a robustly quantifiable bioassay that resolves MOD-1 activation by quipazine, 5-carboxyamidotryptamine and fluoxetine and highlight methiothepin as a potent antagonist...It can be extended to the investigation of other classes of membrane receptors and modulators of neuronal excitation. This approach based on heterologous modulation of the essential M4 neuron function offers a route to discover new effective and selective anthelmintics potentially less confounded by disruptive environmental impact.
  • ||||||||||  ivermectin oral / Generic mfg.
    LUNG CAVITY: A RARE FINDING IN COVID-19 (Convention Center Exhibit Hall: Poster Area) -  Aug 16, 2022 - Abstract #CHEST2022CHEST_1860;    
    The lung cavity in a COVID patient is an under-recognized entity. This case report highlights the need for further studies to determine the cause of cavitation, which could be related to COVID infection or its treatment.